{"id":"https://openalex.org/W4396558768","doi":"https://doi.org/10.1007/s10120-024-01501-w","title":"Adjuvant and post-recurrent treatment patterns in patients with resectable gastric cancer in Japan: a retrospective database cohort study","display_name":"Adjuvant and post-recurrent treatment patterns in patients with resectable gastric cancer in Japan: a retrospective database cohort study","publication_year":2024,"publication_date":"2024-04-30","ids":{"openalex":"https://openalex.org/W4396558768","doi":"https://doi.org/10.1007/s10120-024-01501-w","pmid":"https://pubmed.ncbi.nlm.nih.gov/38689045","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11193688"},"language":"en","primary_location":{"id":"doi:10.1007/s10120-024-01501-w","doi":"https://doi.org/10.1007/s10120-024-01501-w","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10120-024-01501-w","pdf_url":null,"source":{"id":"https://openalex.org/S145569942","display_name":"Gastric Cancer","issn_l":"1436-3291","issn":["1436-3291","1436-3305"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gastric Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1007/s10120-024-01501-w","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040552693","display_name":"Takaki Yoshikawa","orcid":"https://orcid.org/0000-0003-1936-9484","observed_orcids":["https://orcid.org/0000-0003-1936-9484"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takaki Yoshikawa","raw_affiliation_strings":["National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5095963598","display_name":"Yorifumi Kikko","orcid":"https://orcid.org/0000-0002-3693-9517","observed_orcids":["https://orcid.org/0000-0002-3693-9517"]},"institutions":[{"id":"https://openalex.org/I4210148404","display_name":"Bristol-Myers Squibb (Japan)","ror":"https://ror.org/04dbmrm19","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210148404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yorifumi Kikko","raw_affiliation_strings":["Bristol Myers Squibb, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Tokyo, Japan","institution_ids":["https://openalex.org/I4210148404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111295946","display_name":"Reina Makino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Reina Makino","raw_affiliation_strings":["Ono Pharmaceutical Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ono Pharmaceutical Co., Ltd, Osaka, Japan","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5095963599","display_name":"Yuya Kimijima","orcid":"https://orcid.org/0009-0004-4331-6598","observed_orcids":["https://orcid.org/0009-0004-4331-6598"]},"institutions":[{"id":"https://openalex.org/I4210148404","display_name":"Bristol-Myers Squibb (Japan)","ror":"https://ror.org/04dbmrm19","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210148404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuya Kimijima","raw_affiliation_strings":["Bristol Myers Squibb, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Tokyo, Japan","institution_ids":["https://openalex.org/I4210148404"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eiji Nishiyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eiji Nishiyama","raw_affiliation_strings":["Ono Pharmaceutical Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ono Pharmaceutical Co., Ltd, Osaka, Japan","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108925356","display_name":"Yuko Matsuda","orcid":"https://orcid.org/0000-0002-7485-2076","observed_orcids":["https://orcid.org/0000-0002-7485-2076"]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuko Matsuda","raw_affiliation_strings":["Ono Pharmaceutical Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ono Pharmaceutical Co., Ltd, Osaka, Japan","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077533490","display_name":"Bruno Casaes Teixeira","orcid":"https://orcid.org/0000-0003-2366-0960","observed_orcids":["https://orcid.org/0000-0003-2366-0960"]},"institutions":[{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bruno Casaes Teixeira","raw_affiliation_strings":["Bristol Myers Squibb, Uxbridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Uxbridge, UK","institution_ids":["https://openalex.org/I4210125795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018608760","display_name":"Mariella Tejada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariella Tejada","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053675075","display_name":"Robert Carroll","orcid":"https://orcid.org/0000-0003-1561-3769","observed_orcids":["https://orcid.org/0000-0003-1561-3769"]},"institutions":[{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert Carroll","raw_affiliation_strings":["Bristol Myers Squibb, Uxbridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Uxbridge, UK","institution_ids":["https://openalex.org/I4210125795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089443797","display_name":"Shuichi Hironaka","orcid":"https://orcid.org/0000-0001-9714-231X","observed_orcids":["https://orcid.org/0000-0001-9714-231X"]},"institutions":[{"id":"https://openalex.org/I190930483","display_name":"Kyorin University","ror":"https://ror.org/0188yz413","country_code":"JP","type":"education","lineage":["https://openalex.org/I190930483"]},{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shuichi Hironaka","raw_affiliation_strings":["Kyorin University Faculty of Medicine, Tokyo, Japan. shuichi-hironaka@ks.kyorin-u.ac.jp","Saitama Medical University International Medical Center, Saitama, Japan. shuichi-hironaka@ks.kyorin-u.ac.jp","Kyorin University Faculty of Medicine, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0001-9714-231X","affiliations":[{"raw_affiliation_string":"Kyorin University Faculty of Medicine, Tokyo, Japan. shuichi-hironaka@ks.kyorin-u.ac.jp","institution_ids":["https://openalex.org/I190930483"]},{"raw_affiliation_string":"Saitama Medical University International Medical Center, Saitama, Japan. shuichi-hironaka@ks.kyorin-u.ac.jp","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]},{"raw_affiliation_string":"Kyorin University Faculty of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I190930483"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5089443797"],"corresponding_institution_ids":["https://openalex.org/I190930483","https://openalex.org/I4210132452","https://openalex.org/I8588240"],"apc_list":{"value":5290,"currency":"USD","value_usd":5290},"apc_paid":{"value":5290,"currency":"USD","value_usd":5290},"fwci":0.3543,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.57559588,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"27","issue":"4","first_page":"827","last_page":"839"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/resectable-gastric-cancer","display_name":"resectable gastric cancer","score":0.9660000205039978},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.9190000295639038},{"id":"https://openalex.org/keywords/recurrent-gastric-cancer","display_name":"recurrent gastric cancer","score":0.8650000095367432},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.8339999914169312},{"id":"https://openalex.org/keywords/s-1","display_name":"S-1","score":0.8370000123977661},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.8429999947547913},{"id":"https://openalex.org/keywords/ramucirumab","display_name":"ramucirumab","score":0.8569999933242798},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9610000252723694},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.8330000042915344},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.7089999914169312},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.8460000157356262},{"id":"https://openalex.org/keywords/treatment-trends","display_name":"treatment trends","score":0.5289999842643738},{"id":"https://openalex.org/keywords/japan","display_name":"Japan","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9253636598587036},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.7035490274429321},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7002161741256714},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.6383615732192993},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6221813559532166},{"id":"https://openalex.org/C2779551604","wikidata":"https://www.wikidata.org/wiki/Q7290345","display_name":"Ramucirumab","level":3,"score":0.5961856842041016},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5797250270843506},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5450466275215149},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.5156223177909851},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.5029754042625427},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.48077911138534546},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.46744927763938904},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.43060746788978577},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39987367391586304},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.22699928283691406},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.21242755651474}],"mesh":[{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s10120-024-01501-w","doi":"https://doi.org/10.1007/s10120-024-01501-w","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10120-024-01501-w","pdf_url":null,"source":{"id":"https://openalex.org/S145569942","display_name":"Gastric Cancer","issn_l":"1436-3291","issn":["1436-3291","1436-3305"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gastric Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11193688","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11193688","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11193688/pdf/10120_2024_Article_1501.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gastric Cancer","raw_type":"Text"},{"id":"pmid:38689045","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38689045","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s10120-024-01501-w","doi":"https://doi.org/10.1007/s10120-024-01501-w","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10120-024-01501-w","pdf_url":null,"source":{"id":"https://openalex.org/S145569942","display_name":"Gastric Cancer","issn_l":"1436-3291","issn":["1436-3291","1436-3305"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gastric Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320327845","display_name":"Ono Pharmaceutical","ror":"https://ror.org/022jefx64"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4396558768.pdf","grobid_xml":"https://content.openalex.org/works/W4396558768.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1990563741","https://openalex.org/W2000006102","https://openalex.org/W2088971116","https://openalex.org/W2095161320","https://openalex.org/W2098719201","https://openalex.org/W2113947048","https://openalex.org/W2137991416","https://openalex.org/W2164411042","https://openalex.org/W2791609522","https://openalex.org/W2915354646","https://openalex.org/W2932398125","https://openalex.org/W2963921953","https://openalex.org/W2968802677","https://openalex.org/W3006413865","https://openalex.org/W3090309736","https://openalex.org/W3109883399","https://openalex.org/W3171517418","https://openalex.org/W3210406495","https://openalex.org/W4206038052","https://openalex.org/W4238732497","https://openalex.org/W4250948394","https://openalex.org/W4295900264","https://openalex.org/W4388655108"],"related_works":["https://openalex.org/W3204353316","https://openalex.org/W2803919123","https://openalex.org/W3210406495","https://openalex.org/W1982595428","https://openalex.org/W2088971116","https://openalex.org/W4402652824","https://openalex.org/W2089129601","https://openalex.org/W3109734209","https://openalex.org/W2999239400","https://openalex.org/W3000525716"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1,32,211],"study":[2,212],"examined":[3],"temporal":[4,214],"shifts":[5,215],"in":[6,10,69,144,182,205,216],"adjuvant":[7,57,71,92,97,118,123,217],"therapy":[8,25,58],"patterns":[9,20,219,232],"Japanese":[11,237],"patients":[12,68,183],"with":[13,28,53,73,152,184,207,235],"resectable":[14],"gastric":[15],"cancer":[16],"(GC)":[17],"and":[18,23,67,129,141,177,187,200,227],"treatment":[19,158,218,231],"of":[21,35,155,224],"first-line":[22,165],"subsequent":[24],"among":[26],"those":[27,206],"recurrent":[29,150],"disease.":[30],"METHODS:":[31],"retrospective":[33],"analysis":[34],"hospital-based":[36],"administrative":[37],"claims":[38],"data":[39],"(April":[40],"1,":[41,63],"2008":[42,64],"to":[43,83,127,139],"March":[44],"31,":[45],"2022)":[46],"included":[47],"adults":[48],"(aged":[49],"\u2265":[50],"20":[51],"years)":[52],"GC":[54],"who":[55],"started":[56],"on":[59],"or":[60,87,133],"after":[61,91],"October":[62,107],"(adjuvant":[65],"cohort)":[66],"the":[70,81,96,102,149,162,222,236],"cohort":[72,98,151],"disease":[74],"recurrence":[75,84],"(recurrent":[76],"cohort),":[77],"further":[78],"defined":[79],"by":[80],"time":[82],"(\u2264":[85],"180":[86,89],">":[88],"days":[90],"therapy).":[93],"RESULTS:":[94],"In":[95,148],"(n":[99,159],"=":[100,160],"17,062),":[101],"most":[103,163],"common":[104,164],"regimen":[105,119],"during":[106],"2008-May":[108],"2016":[109],"was":[110],"tegafur/gimeracil/oteracil":[111],"potassium":[112],"(S-1;":[113],"95.7%).":[114],"As":[115],"new":[116],"standard":[117],"options":[120],"were":[121,167,233],"established,":[122],"S-1":[124,136,188,192,198],"use":[125,137],"decreased":[126],"65.0%":[128],"fluoropyrimidine":[130],"plus":[131,135,169,173,179,189,193,202],"oxaliplatin":[132,174,190],"docetaxel":[134],"increased":[138],"15.0%":[140],"20.0%,":[142],"respectively,":[143],"September":[145],"2019-March":[146],"2022.":[147],"no":[153],"history":[154],"trastuzumab/trastuzumab":[156],"deruxtecan":[157],"1257),":[161],"regimens":[166],"paclitaxel":[168,201],"ramucirumab":[170,180,203],"(34.0%),":[171],"capecitabine":[172],"(CapeOX;":[175],"17.0%),":[176],"nab-paclitaxel":[178],"(10.1%)":[181],"early":[185],"recurrence,":[186],"(26.3%),":[191],"cisplatin":[194],"(15.3%),":[195],"CapeOX":[196],"(14.0%),":[197],"(13.2%),":[199],"(10.8%)":[204],"late":[208],"recurrence.":[209],"CONCLUSIONS:":[210],"demonstrated":[213],"that":[220,229],"followed":[221],"establishment":[223],"novel":[225],"regimens,":[226],"confirmed":[228],"post-recurrent":[230],"consistent":[234],"Gastric":[238],"Cancer":[239],"Association":[240],"guideline":[241],"recommendations.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-05-02T00:00:00"}